ANTONIOLI, LUCA Statistiche
ANTONIOLI, LUCA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
The role of P2Y receptors in regulating immunity and metabolism
In corso di stampa Lovászi, Marianna; Branco Haas, Clarissa; Antonioli, Luca; Pacher, Pál; Haskó, György
A Novel Mixture Containing Enterococcus lactis SF68® Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms
2026-01-01 Valdiserra, G.; Di Salvo, C.; Campigli, L.; D'Antongiovanni, V.; Pellegrini, C.; Benedetti, G.; Testai, L.; Segnani, C.; Benvenuti, L.; Coppolecchia, R.; Bernardini, N.; Fornai, M.; Antonioli, L.
CCR2-dependent monocytes gut-homing contributes to enteric neuroplastic changes in a mouse model of diet-induced obesity
2026-01-01 Pierucci, Clarissa; Faggin, Sofia; Benvenuti, Laura; Caputi, Valentina; Ippolito, Chiara; Segnani, Cristina; D'Antongiovanni, Vanessa; Valdiserra, Giulia; Flori, Lorenzo; Colucci, Rocchina; Giron, Maria Cecilia; Antonioli, Luca; Bernardini, Nunzia; Pellegrini, Carolina
Corrigendum to 'Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care' [Autoimmunity Reviews 25 (2026) 104068]
2026-01-01 Privitera, Giuseppe; Allocca, Mariangela; Antonioli, Luca; Calabrese, Emma; Caprioli, Flavio Andrea; Castiglione, Fabiana; Danese, Silvio; Daperno, Marco; Dragoni, Gabriele; Fantini, Massimo Claudio; Felice, Carla; Fiorino, Gionata; Orlando, Ambrogio; Pradelli, Lorenzo; Ribaldone, Davide; Rizzello, Fernando; Savarino, Edoardo Vincenzo; Scaldaferri, Franco; Armuzzi, Alessandro
Diosmin Attenuates Age-Associated Vascular Oxidative Stress and Endothelial Dysfunction in Aged Rats
2026-01-01 Valdiserra, G.; Di Salvo, C.; Fornai, M.; Pellegrini, C.; Campigli, L.; Mengozzi, A.; Cappelli, F.; Duranti, E.; Ippolito, C.; Colucci, R.; Bernardini, N.; Virdis, A.; Antonioli, L.
Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study
2026-01-01 Lambiase, C.; Cancelli, L.; Tedeschi, R.; Grosso, A.; Rettura, F.; Salemmo, R.; Bottari, A.; Filippini, F.; Salvadori, S.; Valdiserra, G.; Campigli, L.; Antonioli, L.; Fornai, M.; De Bortoli, N.; Bellini, M.
Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging
2026-01-01 D'Antongiovanni, V.; Salvo, C. D.; Valdiserra, G.; Fornai, M.; Cappelli, F.; Mengozzi, A.; Virdis, A.; Masi, S.; Duranti, E.; Benvenuti, L.; Fiore, W.; De Vitis, V.; Antonioli, L.
Interleukin-10 Autoantibodies in Inflammatory Bowel Disease
2026-01-01 Antonioli, Luca
Is adenosine signalling entering the precision medicine era? From receptor pharmacology to patient stratification
2026-01-01 Antonioli, Luca; Haskó, György
Metabolic reprogramming and intracellular ATP homeostasis in immunity
2026-01-01 Antonioli, L.; Valdiserra, G.; Pacher, P.; Robson, S. C.; Hasko, G.
The Importance of Treatment Timing and Positioning in IBD
2026-01-01 Valdiserra, G.; Fantini, M. C.; Favale, A.; Antonioli, L.
The right drug at the right time: key to IBD success
2026-01-01 Ribaldone, D. G.; Valdiserra, G.; Di Salvo, C.; Puxeddu, I.; Bertani, L.; Antonioli, L.
The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future Perspectives
2026-01-01 Di Salvo, Clelia; Valdiserra, Giulia; Balestrieri, Stefano; Beucci, Giuditta; Paciulli, Giulia; Luculli, Giovanna Irene; De Vita, Alessandro; Fornai, Matteo; Di Paolo, Antonello; Antonioli, Luca
Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling
2025-01-01 Valdiserra, G.; Di Salvo, C.; Fornai, M.; Antonioli, L.
Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity
2025-01-01 D'Antongiovanni, V.; Fornai, M.; Colucci, R.; Nericcio, A.; Benvenuti, L.; Disalvo, C.; Segnani, C.; Pierucci, C.; Ippolito, C.; Nemeth, Z. H.; Hasko, G.; Bernardini, N.; Antonioli, L.; Pellegrini, C.
Multivalent MMP-12 inhibitors as a valuable approach to counteract the intestinal epithelial barrier impairment and inflammation in an in vitro model mimicking intestinal high-fat exposure
2025-01-01 Cuffaro, D.; D'Antongiovanni, V.; Mangini, C.; Di Salvo, C.; Benvenuti, L.; Vandooren, J.; Macchia, M.; Antonioli, L.; Rossello, A.; Fornai, M.; Nuti, E.
Prolonged treatment with probiotics mitigates intestinal dysfunction and enteric Alzheimer's-related pathology in senescence-accelerated mice
2025-01-01 D'Antongiovanni, V.; Pierucci, C.; Benvenuti, L.; Visciglia, A.; Segnani, C.; Ippolito, C.; Antonioli, L.; Fornai, M.; Deusebio, G.; Pane, M.; Amoruso, A.; Bernardini, N.; Pellegrini, C.
Small Intestine Neuromuscular Dysfunctions and Neurogliopathy in a Mouse Model of High-Fat Diet-Induced Obesity: Involvement of Toll-Like Receptor 4
2025-01-01 Faggin, S.; Cerantola, S.; Bosi, A.; Giaroni, C.; Napoli, E.; Savarino, E. V.; Contran, M.; Porzionato, A.; Pellegrini, C.; Antonioli, L.; Caputi, V.; Giron, M. C.
Targeting γ-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axis
2025-01-01 Lambiase, C.; Rettura, F.; Sciume, G. D.; Tedeschi, R.; Grosso, A.; Cancelli, L.; Bottari, A.; Fornai, M.; Antonioli, L.; De Bortoli, N.; Bellini, M.
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study
2024-01-01 Bertani, Lorenzo; Antonioli, Luca; Fornili, Marco; D'Antongiovanni, Vanessa; Ceccarelli, Linda; Carmisciano, Luca; Benvenuti, Laura; Mumolo, Maria Gloria; Bottari, Andrea; Pardi, Veronica; Baiano Svizzero, Giovanni; Baglietto, Laura; De Bortoli, Nicola; Bellini, Massimo; Fornai, Matteo; Costa, Francesco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The role of P2Y receptors in regulating immunity and metabolism | In corso di stampa | Lovászi, Marianna; Branco Haas, Clarissa; Antonioli, Luca; Pacher, Pál; Haskó, György | |
| A Novel Mixture Containing Enterococcus lactis SF68® Restores Gut Barrier Integrity in a DSS-Induced Murine Model of Post-Colitis IBS-like Symptoms | 1-gen-2026 | Valdiserra, G.; Di Salvo, C.; Campigli, L.; D'Antongiovanni, V.; Pellegrini, C.; Benedetti, G.; Testai, L.; Segnani, C.; Benvenuti, L.; Coppolecchia, R.; Bernardini, N.; Fornai, M.; Antonioli, L. | |
| CCR2-dependent monocytes gut-homing contributes to enteric neuroplastic changes in a mouse model of diet-induced obesity | 1-gen-2026 | Pierucci, Clarissa; Faggin, Sofia; Benvenuti, Laura; Caputi, Valentina; Ippolito, Chiara; Segnani, Cristina; D'Antongiovanni, Vanessa; Valdiserra, Giulia; Flori, Lorenzo; Colucci, Rocchina; Giron, Maria Cecilia; Antonioli, Luca; Bernardini, Nunzia; Pellegrini, Carolina | |
| Corrigendum to 'Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care' [Autoimmunity Reviews 25 (2026) 104068] | 1-gen-2026 | Privitera, Giuseppe; Allocca, Mariangela; Antonioli, Luca; Calabrese, Emma; Caprioli, Flavio Andrea; Castiglione, Fabiana; Danese, Silvio; Daperno, Marco; Dragoni, Gabriele; Fantini, Massimo Claudio; Felice, Carla; Fiorino, Gionata; Orlando, Ambrogio; Pradelli, Lorenzo; Ribaldone, Davide; Rizzello, Fernando; Savarino, Edoardo Vincenzo; Scaldaferri, Franco; Armuzzi, Alessandro | |
| Diosmin Attenuates Age-Associated Vascular Oxidative Stress and Endothelial Dysfunction in Aged Rats | 1-gen-2026 | Valdiserra, G.; Di Salvo, C.; Fornai, M.; Pellegrini, C.; Campigli, L.; Mengozzi, A.; Cappelli, F.; Duranti, E.; Ippolito, C.; Colucci, R.; Bernardini, N.; Virdis, A.; Antonioli, L. | |
| Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study | 1-gen-2026 | Lambiase, C.; Cancelli, L.; Tedeschi, R.; Grosso, A.; Rettura, F.; Salemmo, R.; Bottari, A.; Filippini, F.; Salvadori, S.; Valdiserra, G.; Campigli, L.; Antonioli, L.; Fornai, M.; De Bortoli, N.; Bellini, M. | |
| Gut Microbiota Manipulation by Probiotic Lacticaseibacillus paracasei DG I1572 as New Therapeutical Strategy to Counteract Vascular Inflammaging | 1-gen-2026 | D'Antongiovanni, V.; Salvo, C. D.; Valdiserra, G.; Fornai, M.; Cappelli, F.; Mengozzi, A.; Virdis, A.; Masi, S.; Duranti, E.; Benvenuti, L.; Fiore, W.; De Vitis, V.; Antonioli, L. | |
| Interleukin-10 Autoantibodies in Inflammatory Bowel Disease | 1-gen-2026 | Antonioli, Luca | |
| Is adenosine signalling entering the precision medicine era? From receptor pharmacology to patient stratification | 1-gen-2026 | Antonioli, Luca; Haskó, György | |
| Metabolic reprogramming and intracellular ATP homeostasis in immunity | 1-gen-2026 | Antonioli, L.; Valdiserra, G.; Pacher, P.; Robson, S. C.; Hasko, G. | |
| The Importance of Treatment Timing and Positioning in IBD | 1-gen-2026 | Valdiserra, G.; Fantini, M. C.; Favale, A.; Antonioli, L. | |
| The right drug at the right time: key to IBD success | 1-gen-2026 | Ribaldone, D. G.; Valdiserra, G.; Di Salvo, C.; Puxeddu, I.; Bertani, L.; Antonioli, L. | |
| The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future Perspectives | 1-gen-2026 | Di Salvo, Clelia; Valdiserra, Giulia; Balestrieri, Stefano; Beucci, Giuditta; Paciulli, Giulia; Luculli, Giovanna Irene; De Vita, Alessandro; Fornai, Matteo; Di Paolo, Antonello; Antonioli, Luca | |
| Commentary: Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling | 1-gen-2025 | Valdiserra, G.; Di Salvo, C.; Fornai, M.; Antonioli, L. | |
| Enteric glial NLRP3 inflammasome contributes to gut mucosal barrier alterations in a mouse model of diet-induced obesity | 1-gen-2025 | D'Antongiovanni, V.; Fornai, M.; Colucci, R.; Nericcio, A.; Benvenuti, L.; Disalvo, C.; Segnani, C.; Pierucci, C.; Ippolito, C.; Nemeth, Z. H.; Hasko, G.; Bernardini, N.; Antonioli, L.; Pellegrini, C. | |
| Multivalent MMP-12 inhibitors as a valuable approach to counteract the intestinal epithelial barrier impairment and inflammation in an in vitro model mimicking intestinal high-fat exposure | 1-gen-2025 | Cuffaro, D.; D'Antongiovanni, V.; Mangini, C.; Di Salvo, C.; Benvenuti, L.; Vandooren, J.; Macchia, M.; Antonioli, L.; Rossello, A.; Fornai, M.; Nuti, E. | |
| Prolonged treatment with probiotics mitigates intestinal dysfunction and enteric Alzheimer's-related pathology in senescence-accelerated mice | 1-gen-2025 | D'Antongiovanni, V.; Pierucci, C.; Benvenuti, L.; Visciglia, A.; Segnani, C.; Ippolito, C.; Antonioli, L.; Fornai, M.; Deusebio, G.; Pane, M.; Amoruso, A.; Bernardini, N.; Pellegrini, C. | |
| Small Intestine Neuromuscular Dysfunctions and Neurogliopathy in a Mouse Model of High-Fat Diet-Induced Obesity: Involvement of Toll-Like Receptor 4 | 1-gen-2025 | Faggin, S.; Cerantola, S.; Bosi, A.; Giaroni, C.; Napoli, E.; Savarino, E. V.; Contran, M.; Porzionato, A.; Pellegrini, C.; Antonioli, L.; Caputi, V.; Giron, M. C. | |
| Targeting γ-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axis | 1-gen-2025 | Lambiase, C.; Rettura, F.; Sciume, G. D.; Tedeschi, R.; Grosso, A.; Cancelli, L.; Bottari, A.; Fornai, M.; Antonioli, L.; De Bortoli, N.; Bellini, M. | |
| Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn’s Disease: A Prospective Pilot Study | 1-gen-2024 | Bertani, Lorenzo; Antonioli, Luca; Fornili, Marco; D'Antongiovanni, Vanessa; Ceccarelli, Linda; Carmisciano, Luca; Benvenuti, Laura; Mumolo, Maria Gloria; Bottari, Andrea; Pardi, Veronica; Baiano Svizzero, Giovanni; Baglietto, Laura; De Bortoli, Nicola; Bellini, Massimo; Fornai, Matteo; Costa, Francesco |